The global Lung Cancer Diagnostic and Screening Market Growth Accelerated by Early Detection Measures
Lung Cancer Diagnostic and Screening Market Lung cancer is one of the most common and deadly types of cancers, affecting people's quality of life. Factors such as exposure to secondhand smoke, genetics, chemicals also contribute to the rise in lung cancer cases. Early detection through screening and diagnostic tests plays a crucial role in improving patient outcomes and survival rates. Low-dose Computed Tomography (LDCT) scans help detect small lung nodules not visible on chest X-rays. Biomarker tests analyze sputum or blood samples for indications of cancer. The global Lung Cancer Diagnostic and Screening Market is estimated to be valued at US$ 2,585.07 Mn in 2024 and is expected to exhibit a CAGR of 4.1% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights. Market Key Trends The increased emphasis on early detection measures in lung cancer care is one of the primary drivers fueling the growth of the lung cancer diagnostic